Avanos Medical (AVNS) Change in Cash (2013 - 2026)

Avanos Medical has disclosed Change in Cash across 14 years of filings, most recently posting -$24.2 million for Q1 2026.

• Change in Cash for Q1 2026 came in at -$24.2 million, down 126.17% year-over-year; the trailing twelve-month figure through Mar 2026 was -$31.4 million (down 248.11% YoY), and the FY2025 annual result was -$17.9 million, down 189.5% from the prior year.
• Change in Cash came in at -$24.2 million for Q1 2026 at Avanos Medical, down from $19.3 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $25.3 million in Q3 2023 to a low of -$32.0 million in Q1 2023.
• The 5-year median for Change in Cash is -$6.7 million (2025), against an average of -$3.1 million.
• Across the five-year window, Change in Cash soared 1200.0% in 2022 and tumbled 731.82% in 2023, its largest moves.
• Avanos Medical's Change in Cash stood at $10.7 million in 2022, then plunged by 281.31% to -$19.4 million in 2023, then jumped by 196.39% to $18.7 million in 2024, then gained by 3.21% to $19.3 million in 2025, then tumbled by 225.39% to -$24.2 million in 2026.
• The last three Change in Cash figures came in at -$24.2 million (Q1 2026), $19.3 million (Q4 2025), and -$19.8 million (Q3 2025), per Business Quant data.